The heavy chain of the 4F2 cell surface antigen (4F2hc) 1 and the protein related to the b 0,ϩ amino acid transporter (rBAT) are type II membrane glycoproteins with membrane topology atypical to most of the known transporters (1). However, these two proteins have been recently shown to be obligatory for the function of several amino acid transport systems. 4F2hc interacts with different proteins to constitute distinct amino acid transport activities. The 4F2hc-associated amino acid transport proteins thus far identified are LAT1 and LAT2, which are responsible for system L (2-6), y ϩ LAT1 and y ϩ LAT2, which are responsible for system y ϩ L (7, 8), xCT, which is responsible for system x c Ϫ (9), and b 0,ϩ AT (also called 4F2-1c6), which is responsible for system b 0,ϩ (10). The interaction between 4F2hc and b 0,ϩ AT to constitute the amino acid transport system b 0,ϩ , reported from our laboratory recently (10), was an unexpected finding because available evidence suggests that only rBAT is associated with system b 0,ϩ (1). The b 0,ϩ amino acid transport system is Na ϩ -independent and accepts zwitterionic amino acids as well as cationic amino acids as substrates (1, 11, 12) . We observed that the cloned b 0,ϩ AT interacts with 4F2hc to induce the Na ϩ -independent transport of the zwitterionic amino acid alanine and that rBAT is unable to substitute for 4F2hc under similar conditions (10). The 4F2hc⅐b 0,ϩ AT complex-induced alanine transport is inhibitable by zwitterionic amino acids as well as cationic amino acids, confirming the identity of the induced transport activity as system b 0,ϩ . Here we report an interesting finding that both 4F2hc and rBAT can interact independently with b 0,ϩ AT to induce the Na ϩ -independent transport of the cationic amino acid arginine. Of even greater significance of the present study are the findings that although the amino transport activities induced by the two heteromeric complexes 4F2hc⅐b 0,ϩ AT and rBAT⅐b 0,ϩ AT have similar substrate specificity and represent system b 0,ϩ , there are marked differences in substrate affinities between the two complexes. The current prevailing notion is that 4F2hc and rBAT function to chaperone the associated proteins (LAT1, LAT2, y ϩ LAT1, y ϩ LAT2, xCT, and b 0,ϩ AT) by covalent interaction to bring the heteromeric complex to the plasma membrane, and available the evidence strongly supports such a function (3, 5, 8, 13) . Our present studies suggest that 4F2hc and rBAT also influence the catalytic function of the heteromeric complexes by modulating the substrate affinities. The studies reported here thus unravel a novel function of the heavy chains 4F2hc and rBAT in the transport activity of the heteromeric b 0,ϩ amino acid transporter.
The heavy chain of the 4F2 cell surface antigen (4F2hc) 1 and the protein related to the b 0,ϩ amino acid transporter (rBAT) are type II membrane glycoproteins with membrane topology atypical to most of the known transporters (1) . However, these two proteins have been recently shown to be obligatory for the function of several amino acid transport systems. 4F2hc interacts with different proteins to constitute distinct amino acid transport activities. The 4F2hc-associated amino acid transport proteins thus far identified are LAT1 and LAT2, which are responsible for system L (2-6), y ϩ LAT1 and y ϩ LAT2, which are responsible for system y ϩ L (7, 8) , xCT, which is responsible for system x c Ϫ (9), and b 0,ϩ AT (also called 4F2-1c6), which is responsible for system b 0,ϩ (10) . The interaction between 4F2hc and b 0,ϩ AT to constitute the amino acid transport system b 0,ϩ , reported from our laboratory recently (10) , was an unexpected finding because available evidence suggests that only rBAT is associated with system b 0,ϩ (1). The b 0,ϩ amino acid transport system is Na ϩ -independent and accepts zwitterionic amino acids as well as cationic amino acids as substrates (1, 11, 12) . We observed that the cloned b 0,ϩ AT interacts with 4F2hc to induce the Na ϩ -independent transport of the zwitterionic amino acid alanine and that rBAT is unable to substitute for 4F2hc under similar conditions (10) . The 4F2hc⅐b 0,ϩ AT complex-induced alanine transport is inhibitable by zwitterionic amino acids as well as cationic amino acids, confirming the identity of the induced transport activity as system b 0,ϩ . Here we report an interesting finding that both 4F2hc and rBAT can interact independently with b 0,ϩ AT to induce the Na ϩ -independent transport of the cationic amino acid arginine. Of even greater significance of the present study are the findings that although the amino transport activities induced by the two heteromeric complexes 4F2hc⅐b 0,ϩ AT and rBAT⅐b 0,ϩ AT have similar substrate specificity and represent system b 0,ϩ , there are marked differences in substrate affinities between the two complexes. The current prevailing notion is that 4F2hc and rBAT function to chaperone the associated proteins (LAT1, LAT2, y ϩ LAT1, y ϩ LAT2, xCT, and b 0,ϩ AT) by covalent interaction to bring the heteromeric complex to the plasma membrane, and available the evidence strongly supports such a function (3, 5, 8, 13) . Our present studies suggest that 4F2hc and rBAT also influence the catalytic function of the heteromeric complexes by modulating the substrate affinities. The studies reported here thus unravel a novel function of the heavy chains 4F2hc and rBAT in the transport activity of the heteromeric b 0,ϩ amino acid transporter.
EXPERIMENTAL PROCEDURES
Materials-The human retinal pigment epithelial (HRPE) cell line 165, used in expression studies, has been described earlier from our laboratory (14) . COS-1 cells were obtained from the American Type Culture Collection (Manassas, VA). The human rBAT cDNA and rat 4F2hc cDNA were provided by Matthias A. Hediger (Harvard University, Boston, MA). The human 4F2hc cDNA was isolated from a JAR human placental trophoblast cell line cDNA library (15) using the rat 4F2hc cDNA as a probe. The human b 0,ϩ AT cDNA and the murine b 0,ϩ AT cDNA were isolated from a Caco-2 cell (a human intestinal cell line) cDNA library (16) and a mouse kidney cDNA library (17) , respectively, using the rabbit b 0,ϩ AT cDNA as a probe. Functional Expression of the cDNAs in HRPE Cells-The vaccinia virus expression system was used to functionally characterize the cDNAs (4, 10, (15) (16) (17) . The cDNAs of the mouse and human b 0,ϩ ATs, human 4F2hc, and human rBAT were all cloned into pSPORT such that the sense transcription was under the control of the T7 promoter. The cDNAs were transfected into HRPE or COS-1 cells grown in 24-well tissue culture plates using Lipofectin, and the functional expression of the cDNAs was analyzed 12 h later by measuring the uptake of 3 Hamino acids. One microgram of the plasmid carrying the specific cDNA (b 0,ϩ AT, 4F2hc, or rBAT) was used/well. Sister wells transfected iden-* This work was supported by National Institutes of Health Grants DA 10045 and HD 33347. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed. AT. The transport values measured in vector-transfected cells represented the endogenous activity mediated by the amino acid transport systems expressed constitutively in these cells. These values were subtracted from the transport values measured in cells expressing the 4F2hc⅐b 0,ϩ AT complex or the rBAT⅐b 0,ϩ AT complex to calculate the transport activities attributed specifically to these complexes. The transport buffer was composed of 25 mM Hepes/Tris (pH 7.5), supplemented with 140 mM N-methyl-D-glucamine chloride, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgSO 4 , and 5 mM glucose. The incubation time for the transport measurements was 15 min at 37°C following which the uptake medium was aspirated off, and the cells were washed with 2 ϫ 2 ml of ice-cold transport buffer. The cells were then solubilized in 0.5% SDS in 0.2 N NaOH and transferred to vials, and radioactivity associated with the cells was quantitated by liquid scintillation spectrometry. The experiments were repeated two to three times with independent transfections, each done in duplicate or triplicate. Data are presented as mean Ϯ S.E. of these replicate measurements.
In Situ Hybridization-Adult mouse kidneys were collected and immediately frozen in liquid nitrogen. Unfixed 12-m serial sections were prepared on a cryostat, mounted on 2% 3-aminopropyltriethoxysilanecoated slides, air-dried for 10 min, and then stored at Ϫ70°C until required. Nonradioactive in situ hybridization using digoxigenin-UTPlabeled probes was performed on tissue sections as described previously (18) . Riboprobes (sense and antisense) were prepared from partial fragments of mouse b 0,ϩ AT cDNA, mouse 4F2hc cDNA, and mouse rBAT cDNA. The mouse b 0,ϩ AT cDNA fragment (ϳ1.2 kilobase pairs) was obtained by digestion of the full-length cDNA with SalI/KpnI and subcloned into pSPORT vector. The mouse 4F2hc cDNA fragment (ϳ0.7 kilobase pairs) and the mouse rBAT cDNA fragment (ϳ1.0 kilobase pairs) were generated by reverse transcriptase-polymerase chain reaction based on published nucleotide sequences of these clones (19, 20) , and the reverse transcriptase-polymerase chain reaction products were subcloned into pGEM-T vector. The clones were sequenced to confirm their identity and also to determine their orientation. Sense (negative control) and antisense probes were synthesized with appropriate RNA polymerases after linearization of the plasmids with suitable restriction enzymes. The riboprobes were labeled using a digoxigenin-labeling kit (Roche Molecular Biochemicals).
RESULTS AND DISCUSSION

Structural Features of Murine b
0,ϩ AT-The murine b 0,ϩ AT cDNA is 1795 base pairs long with an open reading frame coding for a protein of 487 amino acids (GenBank TM accession no. AF192310). The predicted amino acid sequence is highly homologous to rabbit b 0,ϩ AT with 85% identity and 93% similarity.
Transport Function of 4F2hc⅐b 0,ϩ AT and rBAT⅐b 0,ϩ AT Complexes-Our previous studies have shown that rabbit b 0,ϩ AT interacts with human 4F2hc to induce Na ϩ -independent transport of alanine and that human or rat rBAT cannot substitute Interaction of b 0,ϩ AT with 4F2hc and rBATfor human 4F2hc in inducing alanine transport (10) . In the present study, we co-expressed mouse b 0,ϩ AT with either human 4F2hc or human rBAT and assessed the ability of these two heteromeric complexes to induce the transport of six different amino acids (Fig. 1) . The concentration of the amino acids was 1 M. The 4F2hc⅐b 0,ϩ AT complex was able to mediate the transport of the neutral amino acids alanine, glutamine, serine, threonine, and leucine as well as the transport of the cationic amino acid arginine. These results are similar to those reported previously with rabbit b 0,ϩ AT (10). In contrast, the rBAT⅐b 0,ϩ AT complex was unable to induce the transport of the neutral amino acids. Interestingly, the complex was able to mediate the transport of arginine.
We then compared the substrate specificity of the transport processes associated with the 4F2hc⅐b 0,ϩ AT and rBAT⅐b 0,ϩ AT complexes. This was done by assessing the ability of unlabeled amino acids (2 mM) to inhibit the transport of (Table I) . The 4F2hc⅐b 0,ϩ AT complex-mediated [ 3 H]glutamine transport was completely inhibited by the neutral amino acids alanine, glutamine, and leucine as well as by the cationic amino acids arginine and lysine. The anionic amino acid glutamate and the methylated amino acid methylaminoisobutyric acid had no or minimal effect on this transport. Interestingly, the inhibitory pattern was identical in the case of rBAT⅐b 0,ϩ AT complex-mediated [ 3 H]arginine transport. This transport also was almost completely abolished by neutral amino acids and cationic amino acids but not affected by glutamate and methylaminoisobutyric acid. These data show that the 4F2hc⅐b 0,ϩ AT complex as well as the rBAT⅐b 0,ϩ AT complex induce amino acid transport activities with substrate specificity similar to that of system b 0,ϩ . HRPE cells possess considerable transport activity for several amino acids mediated by transport systems that are expressed constitutively in these cells. These activities were detectable in cells transfected with vector alone. We did not attempt to characterize in detail these endogenous transport activities. However, when the transport of amino acids in vector-transfected cells was analyzed, there was evidence for the expression of a b 0,ϩ -like transport activity in these cells. The evidence included the inhibition of the Na ϩ -independent glutamine transport by various neutral amino acids as well as by cationic amino acids and also the inhibition of the Na ϩ -independent arginine transport by various neutral amino acids as well as by cationic amino acids. There was also evidence for the expression of a transport system belonging to the cationic amino acid transport family. This was suggested by the findings that the Na ϩ -independent transport of radiolabeled arginine was completely inhibited by unlabeled arginine, whereas neutral amino acids showed only a partial inhibitory effect.
Whereas the interaction of the 4F2hc⅐b 0,ϩ AT complex with cationic and neutral amino acids was evident from actual transport measurements as well as from competition experiments, it was not the case with the rBAT⅐b 0,ϩ AT complex. The interaction of the rBAT⅐b 0,ϩ AT complex with cationic and neutral amino acids was demonstrable with competition experiments, whereas when actual transport measurements were made, only the transport of cationic amino acids was detectable. To determine if this difference is related to differences in substrate affinities between the two complexes, we compared the dose-response relationship for the inhibition of ) uptake (B and D) . Only the uptake values specific to the heteromeric complexes were used in the analysis. m, mouse. AT complexes Uptake measurements were made as described in Table I, except 
Interaction of b 0,ϩ AT with 4F2hc and rBAT
and cystine (Fig. 2) . The IC 50 values (i.e. concentration of the amino acid causing 50% inhibition) calculated from these studies are given in Table II . These IC 50 values are almost equal to K i values (i.e. inhibition constant) under the experimental conditions because the concentration of radiolabeled glutamine and arginine used in these competition experiments is 1 M, a value severalfold lower than the known K t values of system b 0,ϩ for glutamine and arginine (11) . A comparison of these values indicates that the affinities of the rBAT⅐b 0,ϩ AT complex for neutral amino acids are three to seven times lower than the corresponding affinities of the 4F2hc⅐b 0,ϩ AT complex. A similar difference is seen in the case of arginine (ϳ10-fold difference), lysine (ϳ2-fold difference), and cystine (ϳ3-fold difference). In accordance with these findings, the rBAT⅐b 0,ϩ AT complex-mediated transport of the neutral amino acids alanine and glutamine became detectable when the concentration of the amino acids during uptake measurements was 50 M instead of 1 M (data not shown).
Because the transport function of the 4F2hc⅐b 0,ϩ AT complex and the rBAT⅐b 0,ϩ AT complex was detectable with arginine as the substrate, we determined directly the affinity of the two complexes for this amino acid (Fig. 3) . The transport of arginine mediated by the 4F2hc⅐b 0,ϩ AT complex was saturable over the arginine concentration range of 2.5-60 M. The MichaelisMenten constant (K t ) for the transport activity was 12.4 Ϯ 1.1 M. This value is comparable to the K i value calculated for this amino acid (12.2 Ϯ 1.8 M) to inhibit glutamine transport mediated by the complex. The transport of arginine mediated by the rBAT⅐b 0,ϩ AT complex was also saturable but at a much higher concentration range of arginine (10 -400 M). The K t value for the transport activity was 88.3 Ϯ 8.7 M. This value is comparable to the K i value for this amino acid (unlabeled form) to inhibit the transport of radiolabeled arginine mediated by the complex (115.8 Ϯ 17.9 M) .
These results are very interesting as they provide evidence for the first time that 4F2hc and rBAT actually influence the 
functional characteristics of the heteromeric complexes in which 4F2hc or rBAT is associated with b 0,ϩ AT as a common component. This is a novel finding because it is presently believed that 4F2hc and rBAT are only responsible for proper trafficking of the heteromeric amino acid transport complexes to the plasma membrane. These complexes consist of either 4F2hc or rBAT as the heavy chain and one of a multitude of transport proteins as the light chain. Neither the heavy chain nor the light chain is competent of amino acid transport when expressed independently. However, when co-expressed, the heavy chain and the light chain constitute a functional transport complex. The currently held notion is that the light chain is the actual transporter and that the heavy chain is obligatory to chaperone the light chain to the plasma membrane. Present studies show that the heavy chains have additional functions in the transport complexes. These subunits modulate the transport function of the complexes by influencing the substrate affinity. We were able to detect this novel function of 4F2hc and rBAT because of the fortuitous observation that b 0,ϩ AT can interact with either of these heavy chains. Apparently, this is not the case with LAT1, LAT2, y ϩ LAT1, y ϩ LAT2, and xCT that are assumed to interact with only 4F2hc (2-9). The possible influence of 4F2hc in these transport systems could not be investigated because the light chains do not have detectable transport activity when expressed alone. In contrast, b 0,ϩ AT is able to associate with either 4F2hc or rBAT to constitute a transport-competent heteromeric complex. This made it possible to detect the influence of the heavy chains on the substrate affinity of the transport system by comparing the characteristics of the two heteromeric complexes containing either 4F2hc or rBAT as the heavy chain.
While this manuscript was in preparation, there were two reports on the cloning and functional characterization of human b 0,ϩ AT (22) and rat b 0,ϩ AT (21) . These reports showed that human b 0,ϩ AT as well as rat b 0,ϩ AT were able to associate only with rBAT. 4F2hc was unable to substitute for rBAT. These results contrast with the data from our previous (10) and current studies. The functional expression of human b 0,ϩ AT and rat b 0,ϩ AT, reported by other investigators, was carried out in COS-1 or COS-7 cells (21, 22) . In contrast, our studies employed HRPE cells. To determine whether the observed differences could be explained on the basis of the different cell lines used, we investigated the transport function of the 4F2hc⅐b 0,ϩ AT complex by co-expressing 4F2hc and mouse b 0,ϩ AT in COS-1 cells (Fig. 4A) . We found that the complex was able to induce the transport of alanine, glutamine, and arginine even in COS-1 cells. An alternative possibility is that the observed differences could be because of species-dependent variations in the ability of b 0,ϩ AT to interact with 4F2hc and/or rBAT. Although mouse b 0,ϩ AT is able to associate with 4F2hc as well as rBAT, it is possible that human and rat b 0,ϩ ATs may interact only with rBAT. To test this possibility, we isolated the b 0,ϩ AT cDNA from a Caco-2 cell cDNA library and investigated its transport function when co-expressed with either 4F2hc or rBAT in HRPE cells (Fig. 4B) . These studies show that human b 0,ϩ AT also is able to interact with 4F2hc as well as rBAT to constitute a functionally competent heteromeric transporter complex. Therefore, we do not have an explanation at present for the data from other groups of investigators showing that b 0,ϩ AT interacts with rBAT and not with 4F2hc. Because b 0,ϩ AT associates with 4F2hc as well as with rBAT, we investigated the regional distribution of mRNA for these three proteins in the mouse kidney by in situ hybridization (Fig. 5) . b 0,ϩ AT-specific mRNA was detectable in the cortex and also in the outer layer of the medulla. The hybridization signal was, however, higher in the cortex than in the outer layer of the medulla. An exactly identical pattern of expression was seen in the case of 4F2hc mRNA. In both cases, the signal was abundant in proximal convoluted tubules, but proximal straight tubules were also clearly positive for the signal. In contrast, the distribution pattern of rBAT mRNA was clearly different. The hybridization signal was more prominent in the outer layer of the medulla than in the cortex. The proximal straight tubules showed a very strong hybridization signal, but proximal convoluted tubules were also clearly positive for the signal. Even though the distribution pattern of b 0,ϩ AT mRNA was similar to that of 4F2hc mRNA but was different from that of rBAT mRNA, there were regions in the kidney where the expression of all three mRNAs overlapped with one another. It is therefore very likely that the 4F2hc⅐b 0,ϩ AT complex as well as the rBAT⅐b 0,ϩ AT complex mediate the b 0,ϩ -like amino acid transport activity in the kidney. Interestingly, there were also regions in the kidney where only the expression of rBAT mRNA was detectable with no evidence for the expression of b 0,ϩ AT mRNA and 4F2hc mRNA. The different distribution pattern of rBAT mRNA from that of b 0,ϩ AT mRNA suggests that there may be other proteins, hitherto unidentified, that interact with rBAT. We speculated in our previous paper that b 0,ϩ AT is a candidate gene for cystinuria (10) . A recent study by the International Cystinuria Consortium (22) has identified mutations in the b 0,ϩ AT gene in several patients with this disease.
